Technical Director at MMIC, CPI
Katie is a chemical engineer with over 25 years’ experience in the pharmaceutical industry. She started her career in process development and scale-up roles with both Merck and Co. in the US and AstraZeneca in the UK, before moving to technical leadership roles in the deployment of technology into large capital projects, also at AstraZeneca. Her expertise covers both drug substance and drug product development and manufacture.
In 2020 Katie joined the Centre for Process Innovation’s Medicines Manufacturing Innovation Centre (MMIC). This is a cross industry-academia-UK government collaboration to drive the adoption of more efficient, cost-effective and environmentally friendly technology to increase patient access to medicines and reduce the manufacturing carbon footprint, through the execution of ambitious, transformational Grand Challenges. As the Technical Director for MMIC, she is responsible for leading the development and delivery of the technology strategy and has accountability for the Grand Challenge portfolio.
23 September 2021
CATCH UP ON DEMAND